Literature DB >> 32372033

Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

John DeLuca1, Nancy D Chiaravalloti2, Brian M Sandroff3.   

Abstract

Cognitive impairment is a common and devastating manifestation of multiple sclerosis (MS). Although disease-modifying therapies have been efficacious for reducing relapse rates in MS, such treatments are ineffective for treating cognitive dysfunction. Alternative treatment approaches for mitigating cognitive problems are greatly needed in this population. To date, cognitive rehabilitation and exercise training have been identified as possible candidates for treating MS-related cognitive impairment; however, cognitive dysfunction is still often considered to be poorly managed in patients with MS. This Review provides a comprehensive overview of recent developments in the treatment and management of cognitive impairment in people with MS. We describe the theoretical rationales, current states of the science, field-wide challenges and recent advances in cognitive rehabilitation and exercise training for treating MS-related cognitive impairment. We also discuss future directions for research into the treatment of cognitive impairment in MS that should set the stage for the inclusion of cognitive rehabilitation and exercise training into clinical practice within the next decade.

Entities:  

Mesh:

Year:  2020        PMID: 32372033     DOI: 10.1038/s41582-020-0355-1

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  197 in total

1.  Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis.

Authors:  Bertrand Audoin; My Van Au Duong; Jean-Philippe Ranjeva; Danielle Ibarrola; Irina Malikova; Sylviane Confort-Gouny; Elisabeth Soulier; Patrick Viout; André Ali-Chérif; Jean Pelletier; Patrick J Cozzone
Journal:  Hum Brain Mapp       Date:  2005-03       Impact factor: 5.038

2.  Cognitive impairment in three subtypes of multiple sclerosis.

Authors:  Douglas R Denney; Lisa A Sworowski; Sharon G Lynch
Journal:  Arch Clin Neuropsychol       Date:  2005-06-14       Impact factor: 2.813

3.  Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.

Authors:  G Bergendal; S Fredrikson; O Almkvist
Journal:  Eur Neurol       Date:  2007-01-01       Impact factor: 1.710

4.  Memory disturbance in multiple sclerosis: reconsideration of patterns of performance on the selective reminding test.

Authors:  W W Beatty; S L Wilbanks; C R Blanco; K A Hames; R Tivis; R H Paul
Journal:  J Clin Exp Neuropsychol       Date:  1996-02       Impact factor: 2.475

5.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

Authors:  Ralph H B Benedict; Diane Cookfair; Rebecca Gavett; Mark Gunther; Frederick Munschauer; Neeta Garg; Bianca Weinstock-Guttman
Journal:  J Int Neuropsychol Soc       Date:  2006-07       Impact factor: 2.892

6.  Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?

Authors:  John DeLuca; Gordon J Chelune; David S Tulsky; Jean Lengenfelder; Nancy D Chiaravalloti
Journal:  J Clin Exp Neuropsychol       Date:  2004-06       Impact factor: 2.475

7.  An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis.

Authors:  Richard H C Lazeron; Serge A R B Rombouts; Philip Scheltens; Chris H Polman; Frederik Barkhof
Journal:  Mult Scler       Date:  2004-10       Impact factor: 6.312

Review 8.  Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.

Authors:  Ralph H B Benedict; John DeLuca; Christian Enzinger; Jeroen J G Geurts; Lauren B Krupp; Stephen M Rao
Journal:  J Int Neuropsychol Soc       Date:  2017-10       Impact factor: 2.892

Review 9.  Cognitive impairment in multiple sclerosis.

Authors:  Nancy D Chiaravalloti; John DeLuca
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

Review 10.  Recommendations for cognitive screening and management in multiple sclerosis care.

Authors:  Rosalind Kalb; Meghan Beier; Ralph Hb Benedict; Leigh Charvet; Kathleen Costello; Anthony Feinstein; Jeffrey Gingold; Yael Goverover; June Halper; Colleen Harris; Lori Kostich; Lauren Krupp; Ellen Lathi; Nicholas LaRocca; Ben Thrower; John DeLuca
Journal:  Mult Scler       Date:  2018-10-10       Impact factor: 6.312

View more
  19 in total

1.  The efficacy of speed of processing training for improving processing speed in individuals with multiple sclerosis: a randomized clinical trial.

Authors:  Nancy D Chiaravalloti; Silvana L Costa; Nancy B Moore; Kristen Costanza; John DeLuca
Journal:  J Neurol       Date:  2022-02-12       Impact factor: 4.849

2.  Managing Cognitive Dysfunction in Multiple Sclerosis: A Snapshot of Changes in Screening, Assessment, and Treatment Practices.

Authors:  Elizabeth S Gromisch; John DeLuca; Ralph H B Benedict; Frederick W Foley
Journal:  Int J MS Care       Date:  2021-09-13

3.  Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocol.

Authors:  Thomas Lehnert; Christian Röver; Sascha Köpke; Jordi Rio; Declan Chard; Andrea V Fittipaldo; Tim Friede; Christoph Heesen; Anne C Rahn
Journal:  Syst Rev       Date:  2022-07-01

4.  Symptom management of patients with multiple sclerosis in primary care: focus on overlooked symptoms.

Authors:  Athanasios Papathanasiou; Laura Saunders; Gillian Sare
Journal:  Br J Gen Pract       Date:  2021-02-25       Impact factor: 5.386

5.  Validity and reliability of the Georgian-language brief international cognitive assessment for multiple sclerosis (BICAMS).

Authors:  Nazibrola Botchorishvili; Nino Shiukashvili; Nina Mikeladze; Ann Dzagnidze; Nino Mikava; Maia Tighashvili; Marina Janelidze
Journal:  BMC Neurol       Date:  2021-06-09       Impact factor: 2.474

6.  Cognitive and Central Vestibular Functions Correlate in People With Multiple Sclerosis.

Authors:  Graham D Cochrane; Jennifer B Christy; Brian M Sandroff; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2021-09-24       Impact factor: 3.919

7.  Delayed access to conscious processing in multiple sclerosis: Reduced cortical activation and impaired structural connectivity.

Authors:  Arzu C Has Silemek; Jean-Philippe Ranjeva; Bertrand Audoin; Christoph Heesen; Stefan M Gold; Simone Kühn; Martin Weygandt; Jan-Patrick Stellmann
Journal:  Hum Brain Mapp       Date:  2021-04-07       Impact factor: 5.038

8.  Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era.

Authors:  Jacqueline A Nicholas; Robert K Shin; Enrique Alvarez; Barry Hendin; Kavita V Nair; Fred D Lublin
Journal:  Mult Scler Relat Disord       Date:  2020-12-24       Impact factor: 4.339

9.  Cognitive Impairment Impacts Exercise Effects on Cognition in Multiple Sclerosis.

Authors:  Annette Rademacher; Niklas Joisten; Sebastian Proschinger; Wilhelm Bloch; Roman Gonzenbach; Jan Kool; Dawn Langdon; Jens Bansi; Philipp Zimmer
Journal:  Front Neurol       Date:  2021-01-28       Impact factor: 4.003

10.  Social Cognition in Multiple Sclerosis: A 3-Year Follow-Up MRI and Behavioral Study.

Authors:  Stefano Ziccardi; Marco Pitteri; Helen M Genova; Massimiliano Calabrese
Journal:  Diagnostics (Basel)       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.